TP53 Gene Mutation: Clinical Trials

1 recruiting, 1 terminated. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Recruiting 1, Terminated 1

Follow TP53 Gene Mutation: new trials by email Literature Review of TP53 Gene Mutation trials Research Report on TP53 Gene Mutation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Oral-ATO for TP53-mutated Myeloid Malignancies Oral arsenic trioxide - Acute Myeloid Leukemia, Myelodysplastic Neoplasm	Phase 2	Recruiting	The University of Hong Kong	30	2025-02-07	2025-06-10
The p53 Colorectal Cancer Trial Cyclophosphamide - Colorectal Cancer Metastatic, Colorectal Cancer Stage IV	Phase 2	Terminated	Haukeland University Hospital	12	2017-05-09	2021-01-22

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Colorectal Neoplasms (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Neoplasms (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)

Interventions

Arsenic Trioxide (1)  ·  Cyclophosphamide (1)

Sponsors

Haukeland University Hospital (1)  ·  The University of Hong Kong (1)

Countries

Hong Kong (1)  ·  Norway (1)

Top investigators

Harinder Gill, MD (1)